Catalyst Wire Dossier Catalyst Wire Dossier

BI 3009947

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 3009947, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood [Phase 1]

See pricing